Rani Therapeutics Holdings, Inc.
RANI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001856725
In the last 90 days, Rani Therapeutics Holdings, Inc. insiders filed 2 open-market purchases and 2 sales; 68 institutions reported holding it in 13F filings for Q2 2026, worth $34.7M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Rani Therapeutics Holdings, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 15 | 22 | +7 |
| Shares | 1.10M | 1.24M | +143.2K (+13.0%) |
| Value | $19.6M | $20.3M | +$725.0K (+3.7%) |
New holders (10)
Institutions that held Rani Therapeutics Holdings, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock Inc. | 114,298 | $1.87M | 0.00% |
| Alpha Square Group S, LLC | 101,603 | $1.66M | 0.34% |
| Advisor Group Holdings, Inc. | 21,072 | $344.0K | 0.00% |
| JPMorgan Chase & Co | 4,186 | $68.0K | 0.00% |
| Morgan Stanley | 3,773 | $61.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 2,646 | $43.0K | 0.00% |
| Citigroup Inc | 864 | $14.0K | 0.00% |
| The PNC Financial Services Group, Inc. | 300 | $5.00K | 0.00% |
| Signaturefd, LLC | 65 | $1.00K | 0.00% |
| Daiwa Securities Group Inc. | 58 | $1.00K | 0.00% |
Sold out (3)
Institutions that held Rani Therapeutics Holdings, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Goldman Sachs Group Inc | 60,649 | $1.08M |
| Millennium Management LLC | 28,996 | $517.0K |
| Northwestern Mutual Wealth Management Co | 1,000 | $18.0K |